Crossref
0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S149
DOI: 10.1016/j.jid.2026.06.892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von R.L. Richmond und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Richmond, R., & Micevic, G. (2026). 0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort. Journal of Investigative Dermatology, 146(8), S149. https://doi.org/10.1016/j.jid.2026.06.892
Vancouver
Richmond R, Micevic G. 0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort. Journal of Investigative Dermatology. 2026;146(8):S149. doi:10.1016/j.jid.2026.06.892
BibTeX
@article{Richmond2026,
author = {Richmond, R.L. and Micevic, G.},
title = {0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S149},
doi = {10.1016/j.jid.2026.06.892}
}
EUVIMED